Answers are grounded in this paper and cite their sources.
Case report reveals cortical laminar necrosis and white matter atrophy after hypoglycemic crisis in Xp21 deletion syndrome, highlighting severe brain injury risk in adrenal disorders.
Background Xp21 deletion syndrome is a rare disorder that causes glycerol kinase deficiency, Duchenne muscular dystrophy, and adrenal hypoplasia congenita (AHC). Currently, there is only one case of hypoglycemic encephalopathy associated with Xp21 deletion syndrome-related AHC has been reported; however, actual images were not provided. Case presentation We describe the case of a 16-month-old boy with Xp21 deletion syndrome–related AHC who developed hypoglycemic encephalopathy during an adrenal crisis. Despite prompt glucose correction, stress-dose steroids, intravenous immunoglobulin, and anticonvulsant therapy, impaired consciousness and seizures persisted. Brain MRI performed 24 h after onset showed bilateral cortical diffusion restriction, most prominently in the occipital lobes. By day 9, diffusion restriction intensified and new subcortical hyperintensities appeared on T2-weighted images. By day 30, diffusion restriction persisted in parts of the bilateral occipital cortex, which also showed faint hyperintensity on T1-weighted and fluid-attenuated inversion recovery images, suggesting cortical laminar necrosis. Additionally, extensive hyperintensities were observed from the subcortical to deep white matter across both hemispheres on T2-weighted images. At 10 months after onset, diffuse white matter atrophy was observed. Conclusion Here, we describe a case of Xp21 deletion syndrome-related AHC complicated by hypoglycemic encephalopathy secondary to adrenal crisis that presented with cortical laminar necrosis and extensive white matter abnormalities. In cases of Xp21 deletion syndrome-related AHC complicated by acute adrenal insufficiency and hypoglycemia, attention should be paid to the potential development of extensive brain injury similar to that observed in congenital adrenal hyperplasia.
No takes yet. Share an insight, caveat, or question.
Seto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: